What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study

OBJECTIVES: Early phase cell therapy trials face many barriers to successful, timely completion. To optimise the conduct of a planned clinical trial of mesenchymal stem cell (MSC) therapy for chronic stroke, we sought patient and physician views on possible barriers and enablers that may influence t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open
Glavni autori: Lalu, Manoj M, Foster, Madison, Presseau, Justin, Dowlatshahi, Dar, Castillo, Gisell, Cardenas, Analyssa, Tam, Whitney, Zlepnig, Jennifer, Timpson, Deborah, Dong, Yuan Yi, Juneau, Pascale, Fergusson, Dean A
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Qualitative Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7103795/
https://ncbi.nlm.nih.gov/pubmed/32198301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-034354
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items